B-lymphoblastic leukemia with DUX4 rearrangement

A B lymphoblastic leukemia/lymphoma that is associated with DUX4 gene rearrangement.

B-lymphoblastic leukemia with MEF2D rearrangement

A B-lymphoblastic leukemia/lymphoma associated with MEF2D gene rearrangement.

B-lymphoblastic leukemia with MYC rearrangement

A B-lymphoblastic leukemia/lymphoma associated with MYC gene rearrangement.

B-lymphoblastic leukemia with NUTM1 rearrangement

A B-lymphoblastic leukemia/lymphoma associated with NUTM1 gene rearrangement.

myeloid and lymphoid neoplasms associated with PDGFRA rearrangement

A myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1 that is characterized by the rearrangement of the PDGFRA gene, most often resulting in the formation of FIP1L1-PDGFRA fusion transcripts.

B-lymphoblastic leukemia with ZNF384 rearrangement

A B-lymphoblastic leukemia/lymphoma associated with ZNF384 gene rearrangement.

myeloid and lymphoid neoplasms associated with PDGFRB rearrangement

A myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1 that is characterized by the rearrangement of the PDGFRB gene, most often resulting in the formation of ETV6-PDGFRB fusion transcripts.

CIC-rearranged sarcoma

An EWSERI-negative small round cell tumor that is characterized by a recurrent translocation involving the CIC gene on chromosome 19 and either DUX4 gene on chromosome 4 or DUX4L gene on chromosome 10. The translocation results in either CIC-DUX4, t(4;19)(q35;q13) or CIC-DUX4L, t(10;19)(q26;q13) fusions.

acute myeloid leukemia with MLL rearrangement

An acute myeloid leukemia characterized by rearrangement of the MLL (mixed-lineage leukemia) gene.

TFE3-rearranged renal cell carcinoma

A renal cell carcinoma with MiT translocations that is characterized by the presence of different translocations involving the chromosome Xp11.2 and that result in the creation of gene fusions involving the TFE3 gene.